The World Health Organization announced on Friday (April 30) that it would include the coronavirus vaccine developed by Modena in the United States on the emergency use list, becoming the fifth coronavirus vaccine certified for emergency use by the WHO.
The Modena vaccine is a vaccine that uses messenger ribonucleic acid (mRNA) technology. The vaccine was reviewed by the WHO immunization strategy advisory group in January this year. The group recommends that people aged 18 and over use this vaccine. .
In December last year, the US Food and Drug Administration approved an emergency use authorization application for the Modena vaccine, and the vaccine was approved by the European Medicines Agency in January this year to be marketed within the European Union.
Prior to this, WHO has issued emergency use certification to four coronavirus vaccines, including the vaccine jointly developed by Pfizer and BioNTech in Germany, and two versions of the AstraZeneca vaccine jointly developed by AstraZeneca and the University of Oxford. And the vaccine developed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson.